Target intelligence / Profile preview

Extended synaptotagmin-2 (ESYT2)

Target
ESYT2
Molecular classification
Other, ER membrane protein, Lipid transfer protein, Membrane contact site tether
01

Overview

Extended synaptotagmin-2 (ESYT2) is a multi-domain endoplasmic reticulum (ER) membrane protein that acts as a tether between the ER and plasma membrane (PM)[2][4][5][6]. It contains a synaptotagmin-like mitochondrial-lipid-binding protein (SMP) domain and multiple C2 domains, which enable regulated contact and lipid transfer between ER and PM[1][2][3][4][5]. ESYT2, together with E-Syt1 and E-Syt3, forms the extended synaptotagmin protein family found in animals and is orthologous to tricalbins in yeast[2][4][5]. Its functions critically depend on calcium binding and the specificity of C2 domains, including Ca2+-dependent and -independent interactions with phospholipids[2][3][5]. ESYT2 is essential for maintaining ER–PM contact site architecture and involved in the transfer of glycerophospholipids, but is not currently established as a direct therapeutic target or implicated in major disease processes[2][5].

Other names
Extended synaptotagmin-2ESYT2E-Syt2FAM62BKIAA1228CHR2SYTChr2Sytextended synaptotagmin like protein 2extended synaptotagmin protein 2family with sequence similarity 62 member Bextended synaptotagmin-2tricalbin (in yeast)
02

Biological functions

ER–plasma membrane tethering[2][4][5]Lipid transfer between endoplasmic reticulum and plasma membrane[2][4][5]Calcium-regulated membrane apposition[2][3][4][5]Maintenance of membrane structure and homeostasis[2][4]
03

Disease associations

Other (No strong evidence directly implicates ESYT2 specifically in major human diseases as of now. Its main role is in cellular homeostasis and signaling.)

Beyond the preview

Go deeper on Extended synaptotagmin-2 (ESYT2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Extended synaptotagmin-2 (ESYT2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call